Table 2.
All | N | |
---|---|---|
Age at first consultation (years) | 27 (22, 36) | 540 |
Duration of hormone therapy (months) | 0 (0, 18) | 457 |
Charlson medical comorbidity index | 0 (0, 1) | 540 |
Hypertensiona | 46 (11.5%) | 540 |
Hypercholesterolemiab | 56 (15.6%) | 540 |
Ischemic heart disease | 4 (0.7%) | 540 |
Human immunodeficiency virus (HIV) | 2 (0.4%) | 540 |
Chronic obstructive airways disease | 79 (14.6%) | 540 |
Liver disease | 25 (4.6%) | 540 |
Venous thromboembolism | 7 (1.5%) | 540 |
Stroke | 1 (0.2%) | 540 |
Cancer/Malignancy | 8 (1.5%) | 540 |
Previous genital reassignment surgery | 46 (8.5%) | 540 |
Body mass index (kg/m2) | 25.6 (22.1, 30.9) | 190 |
Systolic blood pressure (mmHg) | 125 (120, 130) | 397 |
Diastolic blood pressure (mmHg) | 80 (75, 82) | 394 |
Median (IQR) are shown or number (prevalence %) for categorical parameters. N=number of individuals for which data was available.
A hypertension diagnosis was based on antihypertensive treatment.
Hypercholesterolemia diagnosis was based on statin use.